Style de citation APA (7e éd.)

Morganroth, J. e., Moore, E. N. e., & service), S. (. (1989). Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents [electronic resource]: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988. Boston, MA : Springer US.

Style de citation Chicago (17e éd.)

Morganroth, Joel. editor., E. Neil. editor Moore, et SpringerLink (Online service). Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents [electronic Resource]: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988. Boston, MA : Springer US, 1989.

Style de citation MLA (8e éd.)

Morganroth, Joel. editor., et al. Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents [electronic Resource]: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988. Boston, MA : Springer US, 1989.

Style de citation IICA/CATIE

Morganroth, J. e., Moore, E. N. e., ; service), S. (. 1989. Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents [electronic resource]: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988. Boston, MA : Springer US.